Accuray

Accuray
Company typePublic company
Nasdaq: ARAY
Founded1992
FounderJohn R. Adler
Headquarters
Madison, Wisconsin
,
United States
ProductsCyberKnife, tomotherapy

Accuray is a radiation therapy company that develops, manufactures, and sells radiation therapy systems to deliver treatments including stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).[1] It is the developer of innovative technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, the latest generation TomoTherapy platform.[2] The company is headquartered in Sunnyvale, CA, the United States.[3] The platforms are installed in leading healthcare centres in approximately 50 countries globally.

History

Accuray was founded in 1990 by John R. Adler, a Stanford neurosurgeon, and commenced commercial operations in 1992.[4][5]

In February 2007, Accuray was registered under the ticker NASDAQ:ARAY.[6][7] In 2011, Accuray completed its $277 million acquisition of TomoTherapy Inc., creator of advanced radiation therapy solutions for cancer care.[8]

In 2012, the company acquired Morphormics for a total $5.7 million. Morphormics was founded by University of North Carolina at Chapel Hill faculty and specialized in developing imaging software.[9][10]

In 2015, Accuray signed an agreement with RaySearch Laboratories AB to integrate treatment planning support for TomoTherapy, Radixact and CyberKnife.[11]

In July 2019, Accuray joint venture with CNNC Accuray in Tianjin received the license for operating in China.[12][13][14]

In August 2023, Accuray changed its head quarters from Sunnyvale, California USA to Madison, Wisconsin, USA.

Partners

References

  1. ^ "Accuray Is A Promising Radiation Oncology Buy In 2018 (NASDAQ:ARAY) | Seeking Alpha". seekingalpha.com. November 16, 2018. Retrieved January 9, 2023.
  2. ^ "Accuray Incorporated : Annual Report for Fiscal Year Ending --06-30, 2022 (Form 10-K)". August 17, 2022.
  3. ^ Saul, Stephanie (December 17, 2008). "Geography Has Role in Medicare Cancer Coverage". The New York Times. ISSN 0362-4331. Retrieved January 9, 2023.
  4. ^ Development, PodBean. "John Adler: How to Handle Money and Investors | The Health Technology Podcast". rosenman.podbean.com. Retrieved January 9, 2023.
  5. ^ Ward's Business Directory of U.S. Private and Public Companies. Gale Research. 1998. ISBN 978-1-4144-0017-4.
  6. ^ "Accuray IPO raises $288 mln, top of range". Reuters. February 8, 2007. Retrieved January 9, 2023.
  7. ^ Feder, Barnaby J. (February 12, 2008). "A Medical Robot Makes Headway". The New York Times. ISSN 0362-4331. Retrieved January 9, 2023.
  8. ^ "Accuray to buy TomoTherapy for about $277 million". Reuters. March 7, 2011. Retrieved January 9, 2023.
  9. ^ "Accuray to Acquire Morphormics, Inc". Fierce Healthcare. July 19, 2012. Retrieved January 9, 2023.
  10. ^ Garde, Damian (July 17, 2012). "Accuray buys Morphormics for $5.7M". Fierce Biotech. Retrieved January 9, 2023.
  11. ^ "Accuray Extends Ties with RaySearch Laboratories, Stock Up". Nasdaq. October 6, 2015.
  12. ^ "CNNC Accuray Medical Technology receives safety license in China. – Free Online Library". www.thefreelibrary.com. Retrieved January 9, 2023.
  13. ^ Crotti, Nancy (January 28, 2019). "Accuray partners with Chinese company to sell in China". Medical Design and Outsourcing. Retrieved January 9, 2023.
  14. ^ FuturesMarketResearch (February 28, 2019). "Oncology Information System Market – Deep Research Analysis Report on Latest and Future Insights |". Medgadget. Retrieved January 9, 2023.
  15. ^ "Transforming healthcare with software-based technology". Brainlab. Retrieved January 22, 2024.
  16. ^ "GE HealthCare". www.gehealthcare.com. Retrieved January 22, 2024.
  17. ^ "Software in radiation therapy and oncology". RaySearch Laboratories. Retrieved January 22, 2024.
  18. ^ "Delta4 Family". Delta4 Family. Retrieved January 22, 2024.